🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
The standard of care for muscle-invasive bladder cancer (MIBC) is radical c...
Status
Completed
Location
ICO Badalona
Start Date
2018-11-16
Trial ID
NCT03534492
Treatments Being Tested
Despite recent advances in the treatment of Castrate-Resistant Prostate Can...
Status
Completed
Location
Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust,
Start Date
2016-12
Trial ID
NCT02324998
Prospective, multi-center, randomized, open label comparative Phase III stu...
Status
Recruiting
Location
University Clinic Ulm
Start Date
2025-04-22
Trial ID
NCT06643585
Treatments Being Tested
\[Objectives\] Objectives include following to capture safety and efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2018-05-21
Trial ID
NCT03505307
Background: The drug olaparib may stop cancer cells from fixing damage to ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-07-11
Trial ID
NCT03531840
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This is a multicenter single-arm phase II clinical trial to evaluate the ef...
Status
Completed
Location
Hospital Universitario Germans Trias i Pujol
Start Date
2017-10-23
Trial ID
NCT03205761
Treatments Being Tested
This study is phase II, open label, clinical trial to determine the efficac...
Status
Enrolling By Invitation
Location
Yonsei Severance Hospital
Start Date
2020-10-28
Trial ID
NCT04361370
Treatments Being Tested